Hepatotoxicity due to dietary supplements: state-of-the-art, gaps and perspectives

被引:0
|
作者
Rivero-Pino, Fernando [1 ]
Casanova, Alfredo G. [2 ,3 ,4 ]
机构
[1] Univ Seville, Sch Med, Dept Med Biochem Mol Biol & Immunol, Av Sanchez Pizjuan S-N, Seville 41009, Spain
[2] Univ Salamanca, Toxicol Unit, Salamanca, Spain
[3] Inst Biomed Res Salamanca IBSAL, Salamanca, Spain
[4] Grp Translat Res Renal & Cardiovasc Dis TRECARD, Salamanca, Spain
关键词
Adulteration; adverse effects; clinical trials; food safety; quality control; mechanism of action; production process; ANABOLIC-ANDROGENIC STEROIDS; INDUCED LIVER-INJURY; GREEN TEA EXTRACT; FOOD SUPPLEMENTS; WEIGHT-LOSS; ILLICIT USE; HEPATITIS; SAFETY; RHABDOMYOLYSIS; OXYMETHOLONE;
D O I
10.1080/10408444.2023.2282415
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Food supplements are products intended to complement the normal diet and consist of concentrated sources of nutrients or other substances with a nutritional or physiological effect. Although they are generally considered safe if the manufacturer's recommendations are followed, many of them have shown hepatotoxic properties. This can cause many diseases (e.g. steatohepatitis and cirrhosis) characterized by progressive damage and malfunction of the liver that in the long term can lead to death. A review of the literature was carried out to elucidate which dietary supplements have been associated with cases of hepatotoxicity in recent years, with emphasis on those relevant to the consumer and the new trends (e.g. cannabidiol). It has been reported that the supplements described as hepatotoxic are mainly of botanical origin (e.g. green tea or turmeric) and those used in sports (mainly anabolic androgenic steroids). There is a great variability of compounds described as causing liver damage, although sometimes it is not possible to identify them, because they are contaminants or adulterants of the products. In addition, the prevalence of toxic effects after the administration of supplements is difficult to define due to underreporting and the lack of specific studies. Globally regarding hepatotoxicity of dietary supplements, there is a paucity of well-conducted clinical trials on the efficacy of these compounds and the frequency of related liver damage, as the use of these products is largely uncontrolled.
引用
收藏
页码:601 / 610
页数:10
相关论文
共 50 条
  • [21] Herbal and dietary supplements: unregulated hepatotoxicity
    不详
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (11): : 965 - 965
  • [22] Hepatotoxicity of herbal and dietary supplements: an update
    Felix Stickel
    Daniel Shouval
    Archives of Toxicology, 2015, 89 : 851 - 865
  • [23] Hepatotoxicity Induced by Herbal and Dietary Supplements
    Navarro, Victor J.
    Lucena, M. Isabel
    SEMINARS IN LIVER DISEASE, 2014, 34 (02) : 172 - 193
  • [24] Neuroscience and oncology: state-of-the-art and new perspectives
    Winkler, Frank
    CURRENT OPINION IN NEUROLOGY, 2023, 36 (06) : 544 - 548
  • [25] Therapeutic siRNA: State-of-the-Art and Future Perspectives
    Friedrich, Maik
    Aigner, Achim
    BIODRUGS, 2022, 36 (05) : 549 - 571
  • [26] Computer medical monitors: State-of-the-art and perspectives
    Kalyadin, N.I.
    Kuznetsov, P.G.
    Lemenkov, V.A.
    Khodyreva, M.D.
    Meditsinskaya Tekhnika, 2002, (03): : 22 - 25
  • [27] Syngas biomethanation: state-of-the-art review and perspectives
    Grimalt-Alemany, Antonio
    Skiadas, Ioannis V.
    Gavala, Hariklia N.
    BIOFUELS BIOPRODUCTS & BIOREFINING-BIOFPR, 2018, 12 (01): : 139 - 158
  • [28] Desalination at overlimiting currents: State-of-the-art and perspectives
    Nikonenko, Victor V.
    Kovalenko, Anna V.
    Urtenov, Mahamet K.
    Pismenskaya, Natalia D.
    Han, Jongyoon
    Sistat, Philippe
    Pourcelly, Gerald
    DESALINATION, 2014, 342 : 85 - 106
  • [29] Electrochemotherapy in Veterinary Oncology State-of-the-Art and Perspectives
    Spugnini, Enrico Pierluigi
    Baldi, Alfonso
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2019, 49 (05) : 967 - +
  • [30] STATE-OF-THE-ART AND NEW PERSPECTIVES IN DIABETIC NEPHROPATHY
    TIENGO, A
    ACTA DIABETOLOGICA, 1992, 29 (3-4) : 278 - 279